A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
This study investigates the use of cysteamine in the treatment of adults with Cystic Fibrosis
who are experiencing an exacerbation of CF-associated lung disease. There are six different
potential dosing regimens, including one that is placebo.